Breaking News

BioDuro-Sundia Expands Drug Discovery Capacity, Capability

The expansion includes increased IVIS based real-time metastasis and drug distribution analyses.

BioDuro-Sundia has completed discovery capability expansions of more than 100,000 sq. ft of laboratory space within three different R&D Centers in Shanghai Waigaoqiao, Shanghai Zhangjiang, and Beijing. “At BioDuro-Sundia, we are fully invested in our clientele and pro-actively planning ahead to meet their needs,” said Xiang Li, president of BioDuro-Sundia Drug Discovery. The highlights of the expansion include: Discovery Biology department • enlarged HCS capability • developed mor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters